TD Cowen analysts say the rate updates of the Centers for Medicare and Medicaid Services’ proposed rule for hospital outpatient and ambulatory surgery center procedures will be overshadowed by a proposal to eliminate the inpatient only list, which is positive for Surgery Partners (SGRY) and United Surgical Partners (USPI), and the 340B remedy reduction higher from 0.5% to 2.0% per year, which is likely negative for HCA Healthcare (HCA), Tenet Healthcare (THC) and Universal Health (UHS). However, the firm expects this to be lobbied by the American Hospital Association and awaits additional commentary from the industry. The rule projects an overall 2.4% rate update for outpatient hospital and ambulatory surgery center procedures, the analysts tell investors in a research note. Shares of HCA are down 3% to $359.09 in morning trading while Surgery Partners is up 2% to $22.38.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
